CTXR·17322U306·US·equity·Healthcare - Biotechnology-13D/G
CTXR (CITIUS PHARMACEUTICALS INC) is held by 19 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($221,556), BlackRock, Inc. ($62,866), UBS Group AG ($49,522). Net institutional sentiment: Mixed.
See how CTXR's score breaks down across 4 SEC sources
Showing 1-20 of 23
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer